Transforming the Prevention and Treatment of Preeclampsia

Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.